← Leaderboards
John D Roache
University Of Texas Hlth Sci Ctr San Ant
$2,392,034
Attributed
$2,718,634
Total exposure
12
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $653.2K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,718,634 · 11
VA$0 · 1
By mechanism
N01$970,885 · 1
R01$954,249 · 2
R21$738,545 · 2
M01$54,955 · 6
I01$0 · 1
Top collaborators
- John H Krystal5 shared
- Donald M Dougherty1 shared
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Thomas L. Patterson$31,498,176
- Wouter Koek$4,458,124
- Larry Ereshefsky$760,315
- John H Casada$493,847
- Rochelle N Shain$2,022,463
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectPharmacokineticsDoseResponseBaseAlcohol DependenceFundingSelf MedicationGenetic PolymorphismAlprazolamBloodScheduleMedicalSymptomsHourPlacebosDouble-Blind MethodBenzodiazepinesDrug Adverse EffectPharmaceutical PreparationsLifeLaboratoriesComorbidity
Grant awards (22)
Consequences of Substance Use on the Development of Impulse Control$653,200
R01 · FY2021 · DA · contact PI
CAP-Ketamine for antidepressant resistant PTSD$0
I01 · FY2020 · VA
CAP-Ketamine for antidepressant resistant PTSD$0
I01 · FY2019 · VA
CAP-Ketamine for antidepressant resistant PTSD$0
I01 · FY2018 · VA
CAP-Ketamine for antidepressant resistant PTSD$0
I01 · FY2017 · VA
CAP-Ketamine for antidepressant resistant PTSD$0
I01 · FY2016 · VA
Alprazolam Abuse Liability in Post Traumatic Stress Disorder (PTSD)$179,293
R21 · FY2009 · DA · contact PI
Alprazolam Abuse Liability in Post Traumatic Stress Disorder (PTSD)$150,393
R21 · FY2008 · DA · contact PI
DIFFERENTIAL NEUROSTEROID RESPONSES IN PTSD AND ALCOHOL DEPENDENCE$666
M01 · FY2008 · RR · contact PI
DIFFERENTIAL NEUROSTEROID RESPONSES IN PTSD AND ALCOHOL DEPENDENCE$415
M01 · FY2007 · RR · contact PI
PH I ASSESS OF POTENTIAL INTERACTIONS BETWEEN IV COCAINE, ETHANOL, DISULFIRAM$20,069
M01 · FY2006 · RR · contact PI
PH I ASSESS OF INTERACTIONS BETWEEN IV COCAINE, ETHANOL AND DISULFIRAM$18,691
M01 · FY2005 · RR
Clinical-Genetic Variation in GABA /Alcohol Sensitivity$137,720
R21 · FY2004 · AA
Clinical-Genetic Variation in GABA /Alcohol Sensitivity$137,720
R21 · FY2003 · AA
Clinical-Genetic Variation in GABA /Alcohol Sensitivity$133,419
R21 · FY2002 · AA
INDIVIDUAL SENSITIVITY TO ANTIANXIETY MEDICATION$0
M01 · FY2002 · RR
INDIVIDUAL SENSITIVITY TO ANTIANXIETY MEDICATION$0
M01 · FY2002 · RR
INDIVIDUAL SENSITIVITY TO ANTIANXIETY MEDICATION$0
M01 · FY2001 · RR
CLINICAL TRIAL OPERATIONS$970,885
N01 · FY2000 · DA
REINFORCING EFFECTS OF BENZODIAZEPINES IN ANXIETY$301,049
R01 · FY2000 · DA
PHYSIOLOGICAL &BEHAVIORAL EFFECTS OF AMPHETAMINE AND COCAINE IN COMBINATION$15,114
M01 · FY2000 · RR
INDIVIDUAL SENSITIVITY TO ANTIANXIETY MEDICATION$0
M01 · FY2000 · RR